Multiple Sclerosis
What If Your MS Research Could Go Beyond Managing What’s Happening Today?
If you’re living with Multiple Sclerosis (MS), you’ve probably spent a lot of time learning how to manage it—medications, symptoms, flare-ups, MRIs, fatigue, mobility, and the uncertainty of what the future may hold.
But there is another question worth asking:
What is being researched to protect the nervous system, repair damage, and potentially change the course of MS?
You may have heard about “stem cell therapy, ” but finding reliable information can be surprisingly difficult. Some approaches are well studied. Some are still experimental. And some very different treatments are all described with the same words.
We’ve done the digging for you.
Our complimentary Multiple Sclerosis & Regenerative Medicine Research Collection brings together some of the most important human studies and reviews—including research you may not have encountered in your own search.
For example:
One randomized clinical trial found that autologous hematopoietic stem-cell transplantation substantially prolonged the time to disability progression in people with highly active relapsing MS compared with disease-modifying therapy.
Another Phase II trial is investigating whether mesenchymal stem-cell-derived neural progenitors can provide something very different: neuroprotection and repair in progressive MS. Its primary endpoint was not met, but intriguing improvements were observed in walking, bladder function, brain atrophy and biomarkers in certain patients.
And researchers have now taken an even more direct approach—transplanting neural precursor cells into people with progressive MS to explore whether they can support the damaged nervous system. Early human research has provided important safety and biological findings.
There is also fascinating research asking whether regenerative cells work partly through the growth factors and biological signals they release, rather than simply becoming replacement cells themselves.
And importantly, we've included studies that did not show the hoped-for benefit, too.Because, while you may know that just the chance of slowing the progression of MS justifies a thorough education, you need more than a collection of optimistic claims.
You deserve to know what has actually been tested in humans, what looks promising, what has not worked, and what researchers still don't know.
Request our complimentary Multiple Sclerosis & Regenerative Medicine Research Collection and use it as a starting point for your own research and conversations with your neurologist.
Your MS journey is personal. Your decisions should be, too.
No obligation. No pressure.
Just carefully selected information that may help you ask better questions—and make sure you don't overlook something important.
→ Request the MS Complimentary Research Collection